| SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-1273 OMICRON (XBB.1.5) 0.25 ML Injection, 6m through 11y (EUA) |
SY |
| SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-1273 OMICRON (XBB.1.5) 0.5 ML Injection, 12y+ |
PSN |
| SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-1273 OMICRON (XBB.1.5) 0.5 ML Injection, 12y+ |
SY |
| SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-1273 OMICRON (XBB.1.5) 0.5 ML Prefilled Syringe, 12y+ |
PSN |
| SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-1273 OMICRON (XBB.1.5) 0.5 ML Prefilled Syringe, 12y+ |
SY |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.005 MG/0.5 ML Injectable Suspension (EUA) |
SY |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.01 MG/ML Injectable Suspension |
SCD |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) |
PSN |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) |
SY |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 0.01 MG/ML Injectable Suspension |
SCD |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 5 MCG/0.5 ML Injectable Suspension (EUA) |
PSN |
| SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2601 5 MCG/0.5 ML Injectable Suspension (EUA) |
SY |
| Satogesic Hot 0.025 % Medicated Patch |
PSN |
| Satogesic Hot 0.025 % Medicated Patch |
SY |
| Satohap (camphor 5 % / menthol 4 % / methyl salicylate 10 % ) Topical Lotion |
SY |
| Satohap (camphor 5 % / menthol 4 % / methyl salicylate 10 % ) Topical Spray |
SY |
| Satohap (camphor 5 % / menthol 6 % / methyl salicylate 10 % ) Topical Lotion |
SY |
| Satohap (camphor 50 MG/ML / menthol 40 MG/ML / methyl salicylate 100 MG/ML) Topical Spray |
SY |
| SATOHAP 5 % / 4 % / 10 % Topical Lotion |
PSN |
| SATOHAP 5 % / 4 % / 10 % Topical Spray |
PSN |
| SATOHAP 5 % / 6 % / 10 % Topical Lotion |
PSN |
| Satohap Lidocaine 4 % Topical Lotion |
PSN |
| Satohap Lidocaine 4 % Topical Lotion |
SY |
| Satohap Lidocaine 40 MG/ML Topical Lotion |
SY |
| Satohap Pain Relieving (levomenthol 1 % / lidocaine 4 % ) Topical Cream |
SY |
| Satohap Pain Relieving 1 % / 4 % Topical Cream |
PSN |
| satralizumab-mwge 120 MG in 1 ML Prefilled Syringe |
PSN |
| satralizumab-mwge 120 MG per 1 ML Prefilled Syringe |
SY |
| Savaysa 15 MG (as edoxaban tosylate 20.2 MG) Oral Tablet |
SY |
| Savaysa 15 MG Oral Tablet |
PSN |